InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: LutherTiggs post# 19868

Sunday, 07/06/2014 1:12:35 PM

Sunday, July 06, 2014 1:12:35 PM

Post# of 30990

And what will distinguish the neutraceutical from the prescription version being contemplated from a science perspective?



That's what I would like to know. Also, are they planning on building on the chemistry to make a more powerful anti-inflammatory, or are they going to ride 'anatabine' one indication at a time in an attempt to fully leverage their asset?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.